UniProt ID | AP2A2_MOUSE | |
---|---|---|
UniProt AC | P17427 | |
Protein Name | AP-2 complex subunit alpha-2 | |
Gene Name | Ap2a2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 938 | |
Subcellular Localization |
Cell membrane Peripheral membrane protein Cytoplasmic side . Membrane, coated pit Peripheral membrane protein Cytoplasmic side . AP-2 appears to be excluded from internalizing CCVs and to disengage from sites of endocytosis seconds before int |
|
Protein Description | Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. The AP-2 alpha subunit binds polyphosphoinositide-containing lipids, positioning AP-2 on the membrane. The AP-2 alpha subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif.. | |
Protein Sequence | MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTEKQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIANVGSREMAEAFAGEIPKILVAGDTMDSVKQSAALCLLRLYRTSPDLVPMGDWTSRVVHLLNDQHLGVVTAATSLITTLAQKNPEEFKTSVSLAVSRLSRIVTSASTDLQDYTYYFVPAPWLSVKLLRLLQCYPPPDPAVRGRLTECLETILNKAQEPPKSKKVQHSNAKNAVLFEAISLIIHHDSEPNLLVRACNQLGQFLQHRETNLRYLALESMCTLASSEFSHEAVKTHIETVINALKTERDVSVRQRAVDLLYAMCDRSNAQQIVAEMLSYLETADYSIREEIVLKVAILAEKYAVDYTWYVDTILNLIRIAGDYVSEEVWYRVIQIVINRDDVQGYAAKTVFEALQAPACHENLVKVGGYILGEFGNLIAGDPRSSPLIQFNLLHSKFHLCSVPTRALLLSTYIKFVNLFPEVKATIQDVLRSDSQLKNADVELQQRAVEYLRLSTVASTDILATVLEEMPPFPERESSILAKLKKKKGPSTVTDLEETKRERSIDVNGGPEPVPASTSAASTPSPSADLLGLGAVPPAPTGPPPSSGGGLLVDVFSDSASAVAPLAPGSEDNFARFVCKNNGVLFENQLLQIGLKSEFRQNLGRMFIFYGNKTSTQFLNFTPTLICADDLQTNLNLQTKPVDPTVDGGAQVQQVVNIECISDFTEAPVLNIQFRYGGTFQNVSVKLPITLNKFFQPTEMASQDFFQRWKQLSNPQQEVQNIFKAKHPMDTEITKAKIIGFGSALLEEVDPNPANFVGAGIIHTKTTQIGCLLRLEPNLQAQMYRLTLRTSKDTVSQRLCELLSEQF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Malonylation | --MPAVSKGDGMRGL --CCCCCCCCCCHHH | 55.19 | 26320211 | |
6 | Ubiquitination | --MPAVSKGDGMRGL --CCCCCCCCCCHHH | 55.19 | - | |
35 | Malonylation | AEIKRINKELANIRS HHHHHHHHHHHHHHH | 52.30 | 26320211 | |
35 | Ubiquitination | AEIKRINKELANIRS HHHHHHHHHHHHHHH | 52.30 | - | |
53 | Phosphorylation | GDKALDGYSKKKYVC CCCCCCCCCHHHHHH | 19.58 | 25195567 | |
95 | Phosphorylation | YTEKQIGYLFISVLV CCHHHCCCCEEEEEE | 10.48 | 26643407 | |
99 | Phosphorylation | QIGYLFISVLVNSNS HCCCCEEEEEECCCH | 11.32 | 26643407 | |
104 | Phosphorylation | FISVLVNSNSELIRL EEEEEECCCHHHHHH | 33.96 | 26643407 | |
106 | Phosphorylation | SVLVNSNSELIRLIN EEEECCCHHHHHHHH | 33.33 | 26643407 | |
134 | S-palmitoylation | FMGLALHCIANVGSR HHHHHHHHHHHCCCH | 3.06 | 28680068 | |
165 | Ubiquitination | GDTMDSVKQSAALCL CCCHHHHHHHHHHHH | 42.35 | - | |
171 | S-palmitoylation | VKQSAALCLLRLYRT HHHHHHHHHHHHHHH | 2.63 | 28526873 | |
231 | Phosphorylation | TSVSLAVSRLSRIVT HHHHHHHHHHHHHHH | 23.15 | 23737553 | |
234 | Phosphorylation | SLAVSRLSRIVTSAS HHHHHHHHHHHHHCC | 20.89 | 23737553 | |
282 | S-palmitoylation | VRGRLTECLETILNK HHCHHHHHHHHHHHH | 3.33 | 28526873 | |
330 | S-palmitoylation | PNLLVRACNQLGQFL CCHHHHHHHHHHHHH | 2.03 | 28526873 | |
330 | S-nitrosylation | PNLLVRACNQLGQFL CCHHHHHHHHHHHHH | 2.03 | 20925432 | |
330 | S-nitrosocysteine | PNLLVRACNQLGQFL CCHHHHHHHHHHHHH | 2.03 | - | |
353 | S-palmitoylation | YLALESMCTLASSEF HHHHHHHHHHHCCCC | 3.82 | 28526873 | |
396 | S-palmitoylation | VDLLYAMCDRSNAQQ HHHHHHHCCCCCHHH | 2.75 | 28526873 | |
532 | S-palmitoylation | LHSKFHLCSVPTRAL CCCCHHHCCHHHHHH | 2.64 | 28526873 | |
564 | Phosphorylation | TIQDVLRSDSQLKNA HHHHHHHCCHHHCCC | 37.14 | 29899451 | |
569 | Ubiquitination | LRSDSQLKNADVELQ HHCCHHHCCCCHHHH | 42.31 | - | |
614 | Ubiquitination | RESSILAKLKKKKGP HHHHHHHHHHHCCCC | 58.35 | - | |
619 | Ubiquitination | LAKLKKKKGPSTVTD HHHHHHCCCCCCCCC | 82.19 | - | |
619 | Malonylation | LAKLKKKKGPSTVTD HHHHHHCCCCCCCCC | 82.19 | 26320211 | |
622 | Phosphorylation | LKKKKGPSTVTDLEE HHHCCCCCCCCCHHH | 44.15 | 29899451 | |
623 | Phosphorylation | KKKKGPSTVTDLEET HHCCCCCCCCCHHHH | 30.47 | 11758877 | |
625 | Phosphorylation | KKGPSTVTDLEETKR CCCCCCCCCHHHHHH | 34.65 | 29899451 | |
631 | Ubiquitination | VTDLEETKRERSIDV CCCHHHHHHHCCCCC | 56.38 | - | |
635 | Phosphorylation | EETKRERSIDVNGGP HHHHHHCCCCCCCCC | 20.56 | 23649490 | |
692 | Phosphorylation | DVFSDSASAVAPLAP EEECCCCCCCCCCCC | 27.51 | 23649490 | |
807 | Phosphorylation | VLNIQFRYGGTFQNV EEEEEEEECCEECCE | 22.61 | 17203969 | |
841 | Ubiquitination | QDFFQRWKQLSNPQQ HHHHHHHHHCCCHHH | 43.48 | - | |
855 | Ubiquitination | QEVQNIFKAKHPMDT HHHHHHHHCCCCCCC | 53.37 | - | |
902 | S-palmitoylation | TKTTQIGCLLRLEPN ECCCEECEEEECCCC | 3.27 | 28526873 | |
922 | Phosphorylation | YRLTLRTSKDTVSQR EHHHHHCCHHHHHHH | 23.31 | 24719451 | |
927 | Phosphorylation | RTSKDTVSQRLCELL HCCHHHHHHHHHHHH | 16.21 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AP2A2_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AP2A2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AP2A2_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-807, AND MASSSPECTROMETRY. |